B+
Bull case
25%
Probability
Target price
$12.75
Analysis reference price unavailable
Analysis 2025-12-07 · RankAlpha Sentiment AI
COGT
Cogent BiosciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Successful clinical readouts or a partnership deal could drive accelerated adoption of the drug candidate and multiple expansion; bull target assumes ~50% upside vs anchor with positive news.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Clinical failure or need for additional financing would depress valuation; bear target reflects substantial dilution/negative readthroughs and a large drawdown.
Momentum
12
Value
41
Sentiment
0
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.50 · Bull $12.75 · Bear $5.10Analysis 2025-12-07; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-11 • Model: HYBRID_IC_RP
AI Memo
As of 2025-12-07 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-11
Investment thesis
As of 2026-09-11
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-11. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $55.82
Why
Momentum12 · Δ7d +0.7
Value41 · Δ7d -0.0
Sentiment0 · Δ7d 0.0
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Clinical failure or need for additional financing would depress valuation; bear target reflects substantial dilution/negative readthroughs and a large drawdown.
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
No dated catalyst is available.
Upcoming clinical data readout (early-stage program)
Lead driver: Value · See fundamentals
Momentum
12
9% active weight
Current posture
7d trendImproving
Δ7d
+0.7
Δ21d
-27.8
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
0
62% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
0.0
Why this grade
Composite grade F. Momentum 12.1 / Value 41.2 / Sentiment 0.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2025-12-07. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$8.50
Analysis reference price unavailable
Analysis 2025-12-07 · RankAlpha Sentiment AI
B-
Bear case
25%
Probability
Target price
$5.10
Analysis reference price unavailable
Analysis 2025-12-07 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$6.57B
Beta
0.45
Shares Out
173.57M
P/E (TTM) · Derived
-14.8
P/S (TTM)
-
P/FCF (TTM) · Derived
-18.93
Rev YoY
-100.0%
EPS YoY
-12.2%
Gross Margin
-
Op Margin
-
Net Debt
-$661.97M
Current Ratio
13.57
As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data